MedPath

comparative therapeutic evaluation of plain and medicated Bukhoor in the management of nonspecific low back pain.

Not yet recruiting
Conditions
Other specified acquired deformities of musculoskeletal system,
Registration Number
CTRI/2023/01/049134
Lead Sponsor
Aligarh Muslim University
Brief Summary

| |

| --- |

|Background:  Low Back pain especially Non-specific low back pain is very prevalent so we need to find effective alternative treatments having minimal side effects.



Purpose: The purpose of the trial is to find the safe and effective treatment of Non-specific low back pain outside pharmacotherapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Clinically diagnosed patients with low back pain as the chief complaint.
  • characterized by intermittent, recurrent, and episodic problems; and includes four types of pain: local, referred, radicular, and that arising from secondary(protective) muscular spasm.
  • Lower back pain persisting for 4 weeks or more.
  • Patients of either gender.
  • Age bracket 18-50 years.
  • Patient willing to abide for protocol guidelines.
Exclusion Criteria
  • Age below 18 years and above 50 years.
  • Recent low back injury.
  • Pregnant and lactating women.
  • Any specific pathology.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ï‚§VAS30 days.
Improvement in :30 days.
ï‚§Sign symptoms30 days.
ï‚§Oswestry low back pain disability scale30 days.
ï‚§SF-1230 days.
ï‚§Mc Gill Pain Questionnaire.30 days.
Secondary Outcome Measures
NameTimeMethod
ELISAOSI(Oxidative stress index)

Trial Locations

Locations (1)

Ajmal Khan Tibbiya College

🇮🇳

Aligarh, UTTAR PRADESH, India

Ajmal Khan Tibbiya College
🇮🇳Aligarh, UTTAR PRADESH, India
Prof Asia Sultana
Principal investigator
8755199034
aasia.sultana@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.